Eva D. D.
- Country
- Spain
- Department
- Hematology
Research Overview
- Phase 2 Open-Label Study of Brentuximab Vedotin and CHP in Frontline Treatment of Peripheral T-Cell Lymphoma with <10% CD30 Expression
- Evaluation of Brentuximab Vedotin-ESHAP Versus ESHAP in Relapsed/Refractory Classical Hodgkin Lymphoma: A Phase IIb Randomized Study
- Evaluation of Chemotherapy with Nivolumab in Early-Stage Classical Hodgkin Lymphoma with Low Metabolic Tumor Volume and Negative Interim PET
Data & Insights
Has run more than one trial at 15 of 60 partner sites.
Specializations
Lymphoma Research
The investigator specializes in treating various forms of lymphoma, with particular emphasis on both Hodgkin's and non-Hodgkin's lymphoma. Their research encompasses innovative therapeutic approaches for T-cell lymphomas and B-cell lymphomas.
- Classical Hodgkin Lymphoma
- Peripheral T-Cell Lymphoma
- Follicular Lymphoma
- Marginal Zone Lymphoma
Breast Cancer Studies
The investigator focuses on advanced treatments for early-stage breast cancer, particularly in cases involving hormone receptor-positive and HER2-negative disease types. Their work includes evaluation of neoadjuvant therapies and long-term patient outcomes.
- Hormone Receptor-Positive Breast Cancer
- Early Stage Invasive Breast Cancer
- Node-Positive Disease
Prostate Cancer Treatment
The investigator conducts research in metastatic prostate cancer treatment, specifically focusing on castration-naïve patients. Their work includes studies of novel therapeutic combinations and treatment approaches for vulnerable patients.
- Adenocarcinoma of the Prostate
- Metastatic Disease Management
- Hormone Therapy Combinations
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.